Litcius/Paper detail

LBA8 Vaccination against SARS-CoV-2 in patients receiving chemotherapy, immunotherapy, or chemo-immunotherapy for solid tumors

Sjoukje F. Oosting, Astrid A.M. van der Veldt, Corine H. GeurtsvanKessel, Rudolf S.N. Fehrmann, Rob van Binnendijk, Anne‐Marie C. Dingemans, Egbert F. Smit, T. Jeroen N. Hiltermann, Gerco den Hartog, Mathilde Jalving, Theresa Westphal, Animesh Battacharya, Marieke van der Heiden, Christian U. Blank, Marion Koopmans, Cornelis Van, Nynke Y. Rots, Debbie van Baarle, John B.A.G. Haanen, Elisabeth G.E. de Vries

2021Annals of Oncology15 citationsDOIOpen Access PDF

Topics & Concepts

MedicineVaccinationImmunotherapyClinical endpointImmunogenicityInternal medicineAdverse effectChemotherapyAntibodyImmunologyCancerClinical trialSARS-CoV-2 and COVID-19 ResearchCOVID-19 and healthcare impactsCancer Immunotherapy and Biomarkers
LBA8 Vaccination against SARS-CoV-2 in patients receiving chemotherapy, immunotherapy, or chemo-immunotherapy for solid tumors | Litcius